These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 28371465)

  • 61. Urine cytology in monitoring recurrence in urothelial carcinoma after radical cystectomy and urinary diversion.
    Chen H; Liu L; Pambuccian SE; Barkan GA; Quek ML; Wojcik EM
    Cancer Cytopathol; 2016 Apr; 124(4):273-8. PubMed ID: 26566001
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quest to develop a standard screening method for urothelial carcinoma using liquid-based cytology (The Paris System) and CK20.
    Jain K; Datta C; Sengupta M; Pal DK; Chatterjee U
    Indian J Pathol Microbiol; 2023; 66(4):720-726. PubMed ID: 38084522
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of the Implementation and Diagnostic Accuracy of the Paris Classification for Reporting Urinary Cytology in Voided Urine Specimens: A Cyto-Histological Correlation Study in a Cancer Center.
    Lobo J; Lobo C; Leça L; Rodrigues Â; Henrique R; Monteiro P
    Pathobiology; 2023; 90(4):233-240. PubMed ID: 36574757
    [TBL] [Abstract][Full Text] [Related]  

  • 64. DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group.
    Pierconti F; Rossi ED; Cenci T; Carlino A; Fiorentino V; Totaro A; Sacco E; Palermo G; Iacovelli R; Larocca LM; Bassi PF; Martini M
    Cancer Cytopathol; 2023 Mar; 131(3):158-164. PubMed ID: 36262084
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Urine cytology suspicious for urothelial carcinoma: Prospective follow-up of cases using cytology and urine biomarker-based ancillary techniques.
    Montalbo R; Izquierdo L; Ingelmo-Torres M; Galve P; Solé M; Franco A; Ribal MJ; Alcaraz A; Mengual L
    Cancer Cytopathol; 2020 Jul; 128(7):460-469. PubMed ID: 32083810
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
    Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
    Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High apoptotic index in urine cytology is associated with high-grade urothelial carcinoma.
    Yang CS; Chen S; Cramer HM; Wu HH
    Cancer Cytopathol; 2016 Aug; 124(8):546-51. PubMed ID: 27070653
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
    Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
    J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Atypical urothelial cells classified according to the Paris System for Reporting Urinary Cytology: A 2-year experience with histological correlation from a Finnish tertiary care center-low rate and high risk of malignancy.
    Pöyry E; Nykänen V; Pulkkinen J; Viljanen E; Laurila M; Kholová I
    Cancer Cytopathol; 2023 Sep; 131(9):574-580. PubMed ID: 37246298
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Paris System for Reporting Urinary Cytology: A Meta-Analysis.
    Nikas IP; Seide S; Proctor T; Kleinaki Z; Kleinaki M; Reynolds JP
    J Pers Med; 2022 Jan; 12(2):. PubMed ID: 35207658
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
    Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
    Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Urinary tract cytology showing variant morphology and divergent differentiation.
    Arshia A; Hassan FA; Hensley PJ; Allison DB
    Cytopathology; 2024 Mar; 35(2):199-212. PubMed ID: 37919868
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Polyomavirus (BK) cytopathic effect in urine cytology is not associated with high risk of developing high-grade urothelial carcinoma.
    Lu H; Elsheikh TM; Zhang Y
    J Am Soc Cytopathol; 2020; 9(2):84-88. PubMed ID: 32029407
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Utility of the Paris System in Urine Cytology for Improved Screening of High-Grade Urothelial Carcinoma in Bahrain.
    Mahmoud Daoud R; Ali AH; Salim Fredericks S; Daoud S; Gomaa HR; AlHashimi FS
    Cureus; 2024 Mar; 16(3):e57189. PubMed ID: 38681345
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diagnostic Accuracy of the Second Edition of the Paris System for Reporting High-Grade Urothelial Carcinoma in Urinary Cytology.
    Singh A; Khan AA; Ahluwalia C; Ahuja S; Ranga S
    Acta Cytol; 2024; 68(6):525-531. PubMed ID: 39293409
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma.
    Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N
    Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Urine cytology findings in patients with biopsy-confirmed urothelial carcinoma in situ with plasmacytoid features.
    Nichols MM; Reynolds JP; McKenney JK; Nicolas MM; McIntire PJ; Policarpio-Nicolas MLC
    Cancer Cytopathol; 2021 Oct; 129(10):798-804. PubMed ID: 33900681
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Companied P16 genetic and protein status together providing useful information on the clinical outcome of urinary bladder cancer.
    Pu X; Zhu L; Fu Y; Fan Z; Zheng J; Zhang B; Yang J; Guan W; Wu H; Ye Q; Huang Q
    Medicine (Baltimore); 2018 Apr; 97(15):e0353. PubMed ID: 29642177
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of the Paris system for reporting urine cytopathology on predictive values of the equivocal diagnostic categories and interobserver agreement.
    Bakkar R; Mirocha J; Fan X; Frishberg DP; de Peralta-Venturina M; Zhai J; Bose S
    Cytojournal; 2019; 16():21. PubMed ID: 31741668
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Negative predictive value and sensitivity of urine cytology prior to implementation of The Paris System for Reporting Urinary Cytology.
    McIntire PJ; Khan R; Hussain H; Pambuccian SE; Wojcik EM; Barkan GA
    Cancer Cytopathol; 2019 Feb; 127(2):125-131. PubMed ID: 30668891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.